During the past decade, Shanghai Ninth People's Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 1 clinical trials were completed. i.e. 3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Ninth People's Hospital" #1 sponsor was "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 42 trials, followed by "Shanghai Jiao Tong University School of Medicine" with 4 trials sponsored, "Ruijin Hospital" with 2 trials sponsored, "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine" with 2 trials sponsored and "Zhejiang Zylox Medical Device Co., Ltd." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Ninth People's Hospital" #1 collaborator was "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 4 trials as a collaborator, "Fudan University" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "CCRF Consulting Co., Ltd." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Ninth People's Hospital" are "Head and Neck Cancer" (4 trials), "Tooth Diseases" (4 trials), "Head and Neck Squamous Cell Carcinoma" (3 trials), "Scar" (3 trials) and "Acute Kidney Injury" (2 trials). Many other conditions were trialed in "Shanghai Ninth People's Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Ninth People's Hospital" are "Drug" (27 trials), "Device" (15 trials), "Procedure" (14 trials), "Other" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Cisplatin" (3 trials), "Intensity-modulated radiotherapy" (3 trials), "Placebo" (3 trials) and "Apatinib Mesylate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Ninth People's Hospital" are 68 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 23 active trials in "Shanghai Ninth People's Hospital". 3 are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Shanghai Ninth People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Ninth People's Hospital, 5 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".